Rociletinib hydrobromide (CO-1686 hydrobromide) is an orally delivered kinase inhibitor that specifically targets the mutant forms of EGFR including T790M, and the Ki values for EGFRL858R/T790M and EGFRWT are 21.5 nM and 303.3 nM, respectively.
Molecular Weight:
636.46
Purity:
>99%
CAS Number:
[1446700-26-0]
Formula:
C27H29BrF3N7O3
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted
